Brief: Candel Therapeutics Q4 Net Income USD -11.095 Million
28/03/2024 12:06
Mar 28 (Reuters) - Candel Therapeutics Q4 operating expenses USD 10.318 million. * Q4 income from operations USD -10.318 million * Q4 basic EPS USD -0.38
Recent news on Candel Therapeutics
See all newsBrief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Candel Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Candel Therapeutics Reports Second Quarter 2026 Financial Results And Recent Corporate Highlights
Candel Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
Brief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)